BioScrip inks cancer drug deal with Access J&J: Nucynta produced fewer side effects than competitor in trial Amgen gets priority review from FDA Kaletra-Isentress therapy for HIV patients as effective as standard treatments, drug makers say FDA accepts NDA for Eisai's Banzel FDA advisory committee shoots down Vivus' Qnexa Millipore officially becomes part of Merck KGaA Cardinal Health completes Healthcare Solutions Holding acquisition Endo completes HealthTronics acquisition Keryx gets orphan-drug designation for neuroblastoma treatment First Previous 186 187 188 189 190 Next Last
